Experienced management team of subject matter experts across drug development

Prof. Mimi Tang

Chief Executive Officer

Scientific Founder. Clinician researcher, recognized as a global thought leader in allergy, over 330 scientific publications, 25+ years’ experience as a clinical immunologist allergist, research into immune mechanisms driving allergic disease, board and industry advisor.

DR MARK HASLETON

Clinical and Commercial Operations

Over 20 years of global biotech / device and pharma experience, management positions at Bristol Myers-Squibb and Teva Pharmaceuticals, and has a doctorate in molecular biology from Imperial College London.

Cameron Jones

Chief Financial Officer

Finance executive and Chartered Accountant with experience as CFO and Company Secretary of ASX Listed and private healthcare companies. Has supported companies through IPOs, capital raising and M&A transactions.

Kathy Harrison

Director, Intellectual Property

25+ years experience in Australian biotech companies and 9 years in patent attorney practice. Strategic expertise in drug development and intellectual property portfolios.

Bronwyn Pollock

Product Development Technical Services - Consultant

Biotech and pharmaceutical professional with 25+ years experience in drug development, quality and program management, submissions to EMA and US FDA.  Responsible for all aspects of drug development

Lesley White

Regulatory Affairs & CMC

Accomplished senior leader with more than 30 years’ experience supporting the development of novel pharmaceutical products and preparing global registration dossiers for submission to US FDA, EMA and other major regulatory bodies.

Rachelle Kirk-Burnnand

Clinical Operations

Clinical Operations Professional with over 20 years of experience in delivery clinical trials in Australia and globally.  Specialising in Phase I-III trials across various therapeutic areas. Has strong leadership, strategic mindset, and passion for achieving goals to deliver Clinical Programs.